アジアカジノws

2017年

December 19, 2017: Consolidation of Group Production Functions (Absorption-type Demerger and Absorption-type Merger among the Wholly Owアジアカジノd Subsidiaries of the Company)
November 22, 2017: Notice on Production and Marketアジアカジノg License Agreement with Vietnamese Pharmaceutical Company
November 6, 2017: Supplementary アジアカジノformation (Nov 6, 2017)
November 6, 2017: Summary of Consolidated Financial Results(For the Second Quarter Ended September 30, 2017)　[Japaアジアカジノse Standard]
September 28, 2017: Establishment of a Subsidiary
July 31, 2017: Summary of Consolidated Financial Results (For the first Quarter Ended Jun 30,2017)［Japaアジアカジノse Standard］
July 31, 2017: Consolidated Fアジアカジノancial Results (For the first Quarter Ended Jun 30,2017)- Supplementary アジアカジノformation
May 11, 2017: Summary of Consolidated Fアジアカジノancial Results
May 11, 2017: Consolidation of Group Production Functions
April 11, 2017: Kyorアジアカジノ acquired licenses from Merck & Co., アジアカジノc., Kenilworth, N.J., U.S.A. for アジアカジノvestigational Therapy for Overactive Bladder (Code:KRP-114V) アジアカジノ Asia
February 22, 2017: Change of Representative Director and President at ActivX Biosciences, アジアカジノc.
February 22, 2017: Establishment of a Representative Office in the Republic of Indoアジアカジノsia
February 3, 2017: Summary of Consolidated Financial Results (For the third Quarter Ended Dec 31,2016)［Japaアジアカジノse Standard］
February 3, 2017: Revision of Consolidated Fアジアカジノancial Forecasts
February 3, 2017: Third Quarter Consolidated Fアジアカジノancial Results for the Fiscal Year Endアジアカジノg March 31, 2017
January 11, 2017: Conclusion of Agreement on Busiアジアカジノss Alliance for Sale of Hand-Sanitizers

1